Undermining Access to Medicines: Comparison of Five US FTAs
Undermining Access to Medicines: Comparison of Five US FTAs. The US government is using bilateral and regional free-trade agreements (FTAs) to impose unnecessarily stringent intellectual property standards on developing countries that go beyond World Trade Organisation (WTO) rules. These new higher standards favor the short-term commercial interests of US pharmaceutical companies, at the expense of public health in developing countries. Oxfam has analyzed a selection of key US FTAs: The provisions in these agreements go far beyond the obligations required by the WTO Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). The new "TRIPS-plus" obligations in the FTAs close off the public health safeguards available to WTO members under TRIPs and will restrict access to affordable medicines in developing countries.
By Oxfam America, US.